KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) FCF Margin (2016 - 2025)

Historic FCF Margin for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to 3.51%.

  • Eli Lilly's FCF Margin fell 37100.0% to 3.51% in Q4 2025 from the same period last year, while for Dec 2025 it was 13.77%, marking a year-over-year increase of 54200.0%. This contributed to the annual value of 13.77% for FY2025, which is 54200.0% up from last year.
  • As of Q4 2025, Eli Lilly's FCF Margin stood at 3.51%, which was down 37100.0% from 38.34% recorded in Q3 2025.
  • Eli Lilly's 5-year FCF Margin high stood at 38.34% for Q3 2025, and its period low was 14.79% during Q4 2023.
  • Its 5-year average for FCF Margin is 13.01%, with a median of 14.05% in 2023.
  • Per our database at Business Quant, Eli Lilly's FCF Margin plummeted by -307000bps in 2023 and then surged by 220100bps in 2024.
  • Eli Lilly's FCF Margin (Quarter) stood at 24.63% in 2021, then tumbled by -35bps to 15.91% in 2022, then crashed by -193bps to 14.79% in 2023, then skyrocketed by 149bps to 7.22% in 2024, then crashed by -51bps to 3.51% in 2025.
  • Its last three reported values are 3.51% in Q4 2025, 38.34% for Q3 2025, and 8.93% during Q2 2025.